Impaired glucose tolerance in COPD patients with hypoxaemia Source: Eur Respir J 2001; 18: Suppl. 33, 211s Year: 2001
d-ETCO2/d-VO2 is a useful index to evaluate exercise tolerance in COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 285s Year: 2002
Glucose metabolism markers in non-diabetic OSAS patients. Effect of compliance to CPAP treatment Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea Year: 2008
Peripheral insulin resistance accounts for impaired glucose tolerance and is associated with systemic inflammation in COPD Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011
The value of early lactate clearance in evaluating the prognosis of patients with respiratory failure Source: Annual Congress 2009 - Respiratory physiology Year: 2009
Inadequate glucose control in type 2 diabetes is associated with impaired lung function and with systemic inflammation Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009
Clinical characteristics, lung function, quality of life, exercise capacity and inflammatory biomarkers in induced sputum and serum in children and adolescents with uncontrolled severe asthma. Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019
Reduced lung function is an independent risk factor for the development of impaired glucose tolerance? Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD Year: 2011
High sensitivity CRP discriminates in COPD for altered metabolic response at rest and during exercise Source: Eur Respir J 2004; 24: Suppl. 48, 214s Year: 2004
The effects and mechanisms of chronic intermittent hypoxia on insulin resistance and glucose tolerance in non-obese rats Source: Annual Congress 2013 –Of mice and men: sleep disordered breathing Year: 2013
Decreased pulmonary function tests are affected by blood glucose tolerance Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020
Discrepancy of non-invasive inflammatory markers and lung function tests to current level of clinical control in childhood asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009
Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients Source: Annual Congress 2011 - COPD: human studies Year: 2011
Evaluation of association between OSA and metabolic syndrome, insulin resistance and Hs-CRP Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I Year: 2011
Effect of CPAP treatment on endothelial function, inflammatory markers, blood pressure and glucose control in patients with OSAS with emphasis on gender differences Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011
Clinical, functional and polysomnographic evaluation in severely obese patients Source: Eur Respir J 2003; 22: Suppl. 45, 469s Year: 2003
EBC glucose levels predict adverse outcome in ARDS Source: Eur Respir J 2006; 28: Suppl. 50, 183s Year: 2006
Exercise tolerance in clinically stable COPD patients after first admission Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008
Association between arterial hypertension and impaired glucose tolerance (IGT) in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011
Stability of serum biomarkers and their associations with clinical outcomes in COPD patients and controls: a longitudinal study Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009